This inventor holds 1 USPTO granted patent. Top assignee: Allelix Biopharmaceuticals Inc.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: The Innovations of Michael Twist
Introduction
Michael Twist was a notable inventor based in Toronto, Canada. He made significant contributions to the field of biopharmaceuticals, particularly in the treatment of viral infections. His work has had a lasting impact on medical research and treatment methodologies.
Latest Patents
Michael Twist held a patent for the treatment of cytomegalovirus infection. The patent describes anti-cytomegalovirus peptides, with a preferred embodiment being acetyl-[D-Arg].sub.9 -NH.sub.2. This innovation highlights the use of these peptides, either alone or in combination with other anti-CMV compounds, as an effective method for controlling CMV infection.
Career Highlights
Throughout his career, Michael Twist was associated with Allelix Biopharmaceuticals Inc., where he focused on developing innovative treatments for viral infections. His dedication to research and development in this area has contributed to advancements in the medical field.
Collaborations
Michael Twist collaborated with various professionals in the biopharmaceutical industry, including his coworker Martin Sumner-Smith. These collaborations helped to enhance the research and development of effective treatments.
Conclusion
Michael Twist's contributions to the field of biopharmaceuticals, particularly in the treatment of cytomegalovirus infection, have left a significant mark on medical research. His innovative work continues to influence the development of effective therapies today.